Bahija Jallal, CEO of Immunocore, shares her journey in developing biopharmaceutical cancer treatments, focusing on targeted therapies. She discusses the potential of new biotech therapies, advancements in T cell tracking, and the revolutionizing impact of Immunocore's treatment for metastatic uvial melanoma. She reflects on her personal background, the challenges faced by women in the industry, and the importance of diversity of thought in leadership. She serves as a role model for women in science and emphasizes the need for inspiration and humility.